Tribute Pharmaceuticals Canada Inc. Form D Notices of Exempt Offering of Securities
Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.
- 2016-02-05: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2016-02-05; Total offering amount $75,000,000.
- 2015-06-10: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Each option is exercisable for one common share at exercise prices ranging from Cdn$0.41 to Cdn$1.00 for varying periods of up to five years.; Date of first sale Yet to occur; Total offering amount $807,744.
- 2015-06-05: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2015-05-21; Total offering amount $4,098,025.
- 2014-10-21: Federal exemption Rule 506(b); Types of securities offered OptionToAcquire; SecurityToBeAcquired; Each option is exercisable for one common share at exercise prices ranging from Cdn$0.41 to Cdn$1.00 for varying periods of up to five years.; Date of first sale Yet to occur; Total offering amount $275,533.
| Filed | Federal exemption | Types of securities offered | Date of first sale | Total offering amount | Total amount sold | Total remaining to be sold | Investors who have already invested |
|---|---|---|---|---|---|---|---|
| 2016-02-05 | Rule 506(b) | Equity | 2016-02-05 | $75,000,000 | $75,000,000 | $0 | 7 |
| 2015-06-10 D/A | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired; Each option is exercisable for one common share at exercise prices ranging from Cdn$0.41 to Cdn$1.00 for varying periods of up to five years. | Yet to occur | $807,744 | $0 | $807,744 | 2 |
| 2015-06-05 | Rule 506(b) | Equity | 2015-05-21 | $4,098,025 | $4,098,025 | $0 | 2 |
| 2014-10-21 | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired; Each option is exercisable for one common share at exercise prices ranging from Cdn$0.41 to Cdn$1.00 for varying periods of up to five years. | Yet to occur | $275,533 | $0 | $275,533 | 2 |
| 2014-10-21 | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired; Each Series A warrant is exercisable for 1 common share at an exercise price of $0.50 and each Series B warrant is exercisable for 1 common share at an exercise price of $0.60, both for a period of 24 months, subject to acceleration. | Yet to occur | $6,579,082 | $0 | $6,579,082 | 13 |
| 2014-10-21 | Rule 506(b) | OptionToAcquire; SecurityToBeAcquired; Each share purchase warrant is exercisable for one common share at exercise prices ranging from US$0.432 to US$0.70 for varying periods of up to seven years. | 2014-10-01 | $1,118,000 | $0 | $1,118,000 | 1 |